ReviewCancers2022

Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma.

Jie Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.